Quelle prise en charge pour l’endométriose ?
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper discusses the management of endometriosis, exploring various treatment options and approaches.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects] 2010
- [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects] 2010
- Traitement médicamenteux de l'endométriose (adénomyose exclue) 2005
- Traitement médicamenteux de l'endométriose (adénomyose exclue) 2005
References (4)
- Traitement médicamenteux de l'endométriose (adénomyose exclue) via crossref
- Traitement médicamenteux de l'endométriose (adénomyose exclue) via openalex
- [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects] via crossref
- [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects] via openalex
Source provenance
- crossref
- last seen: 2026-08-25T06:41:31.258393+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-21T06:41:41.500114+00:00
License: CC0
· commercial use OK